Nature Immunology SJR and Scopus Metrics: What They Actually Mean
Nature Immunology still has elite specialist immunology metrics, but the real submission question is whether your paper is decisive enough for that room.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: Nature Immunology still has elite Scopus authority as a specialist immunology journal.
Nature Immunology's own journal metrics page (read October 2026) prints a 2025 SJR of 11.131 and SNIP of 4.151. Scopus-based aggregator sources place the 2024 figures at SJR 10.390, impact score 12.14, global rank 81, and h-index 452. That confirms genuine flagship influence. The hard submission question is not whether the journal is strong.
It is whether the manuscript is mechanistically decisive and broad enough to matter across immunology rather than only to one narrow subcommunity.
Direct answer
If your question is whether Nature Immunology still behaves like a top specialist immunology flagship in the Scopus system, the answer is yes.
Metric | Current value | What it tells you |
|---|---|---|
SJR | 11.131 (2025, per Nature Immunology) | prestige-weighted influence remains exceptional for immunology |
Impact Score | 12.14 (2024) | citation density is still high despite recent softening |
Global rank | 81 (2024) | the journal remains near the top of the full global ranking |
h-index | 452 (2024) | the archive has deep long-run immunology influence |
Best quartile | Q1 | the title remains firmly top-tier |
Coverage history | 2000-2025 | this is durable flagship authority, not a short-lived spike |
That profile matters because Nature Immunology is still one of the central rooms for mechanistic immunology that changes how the field interprets systems, pathways, and disease processes.
Overview
The useful summary is that Nature Immunology remains in the flagship specialist lane, but the current 2024 profile is below its older peak. The current Resurchify-based impact score is 12.14, while the SJR remains a very strong 10.390. That still describes a premier journal. It just means authors should stop leaning on stale metric surfaces. For the broader fit picture, see our Nature Immunology journal profile.
What changed in 2024
The 2024 picture is softer than 2023.
- SJR moved down from 11.274 in 2023 to 10.390 in 2024
- impact score moved down from 13.85 to 12.14
- global rank moved from 64 to 81
That matters because it confirms the journal remains elite but is not operating at its strongest recent concentration. For authors, that means mechanistic weight and breadth matter more than legacy prestige assumptions.
Ten-year SJR and Scopus trend
Year | SJR | Impact Score | Global Rank |
|---|---|---|---|
2024 | 10.390 | 12.14 | 81 |
2023 | 11.274 | 13.85 | 64 |
2022 | 10.921 | 14.94 | 63 |
2021 | 9.135 | 13.25 | 83 |
2020 | 9.074 | 9.79 | 93 |
2019 | 9.283 | 9.30 | 83 |
2018 | 13.300 | 13.64 | 44 |
2017 | 14.007 | 15.86 | 43 |
2016 | 15.210 | 15.48 | 31 |
2015 | 11.699 | 12.25 | 56 |
2014 | 14.632 | 10.72 | 37 |
The trend shows a journal that remains elite while clearly operating below its 2014-2018 peak concentration. That does not make the bar easier. It makes the manuscript-shape question more important.
What the trend means in practice
For authors, the trend usually means:
- the journal still expects mechanistic work with broad immunology consequence
- local or descriptive stories remain vulnerable
- the archive is strong enough that one missing mechanistic layer gets exposed quickly
- a strong immunology paper is still not automatically a Nature Immunology paper
That is why technically impressive but interpretively partial studies still miss here.
How Nature Immunology compares with realistic neighbors
Journal | Relative 2024 profile | What the metric profile usually signals |
|---|---|---|
Nature Immunology | SJR 10.390 | flagship specialist immunology journal |
Immunity | similar high-end specialist lane | strong mechanistic immunology room with different editorial feel |
Science Immunology | adjacent elite specialist lane | broad and high-end, sometimes better for cross-field immunology stories |
field-specific immunology journals | materially lower prestige concentration | better fit when the audience is narrower |
This is the useful comparison. Nature Immunology is strongest when the work changes field interpretation rather than only adding one more mechanistic detail.
What editors are really screening for
The official aims page is unusually explicit:
- papers of the highest quality and significance in all areas of immunology
- priority given to translational and or fundamental insight into the workings of the immune system
- fair and rapid review
- decisions on whether to send a manuscript to peer review normally made within two working days
That is why the metric profile stays so strong. The journal is protecting mechanistic consequence, not only novelty language.
What we see in Nature Immunology Metric Questions
For Nature Immunology metric questions, three mistakes recur.
The one-layer-short mistake. Authors often target the journal with papers that are technically strong but still one mechanistic step short of being truly decisive.
The local-community mistake. Another common miss is a story that matters deeply to one immune niche but does not travel broadly enough across immunology.
The prestige-substitution mistake. We also see teams use the journal's status as a substitute for asking whether the manuscript really changes how immunologists think. The SJR confirms authority. It does not rescue an underpowered or overly local story.
That is the practical value of the metrics. They explain why the journal remains severely selective even while its recent metric peak has softened.
What these metrics mean for authors
For authors, the current profile says:
- publication here still carries major immunology signal
- the archive is deep enough that weak interpretation becomes obvious quickly
- mechanistic decisiveness matters more than local technical excellence
- if the manuscript truly fits, the visibility upside remains substantial
The h-index of 452 matters because it reflects a deep archive of immune-system papers that other researchers kept reusing and citing.
Submit If / Think Twice If
Submit if:
- the manuscript is mechanistically decisive
- the implication travels beyond one narrow immune subcommunity
- the evidence package still looks strong after skeptical review
- the work changes interpretation rather than only extending description
Think twice if:
- the paper is technically strong but still one mechanistic layer short
- the audience is mainly one specialized immune niche
- the field consequence needs too much explanation
- a narrower immunology journal is the honest fit
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What should drive the decision after the metrics check
The better question is whether the manuscript is truly a Nature Immunology paper in its current form.
That is why the next useful reads are:
- Nature Immunology journal profile
If the manuscript genuinely changes field interpretation, the upside is real. If it is still too local or one mechanistic layer short, the metrics are mostly a warning against over-targeting. A Nature Immunology submission framing check is a direct way to pressure-test that before submission.
Practical verdict
Nature Immunology still has a genuine flagship Scopus profile as a specialist immunology journal, even though the 2024 metrics sit below the older peak.
For authors, the metric question is already settled. The live question is whether the manuscript has enough mechanistic weight and breadth for the readership the journal actually serves.
- Nature Immunology JIF, Manusights.
Frequently asked questions
Nature Immunology's own journal metrics page (read October 2026) prints a 2025 SJR of 11.131, and Scopus-based aggregators put the 2024 SJR at 10.390. Either keeps it near the top of immunology journals.
Current Scopus-based sources place Nature Immunology's 2024 impact score at 12.14, with a global rank of 81 and h-index of 452.
Because it remains one of the central journals for mechanistically decisive immunology that can influence the broader field rather than one narrow subcommunity.
No. The real question is whether the manuscript is mechanistically decisive and broad enough to change field interpretation.
Sources
- 1. Nature Immunology metrics page, Resurchify.
- 2. Nature Immunology Aims & Scope, Nature Portfolio.
- 3. Nature Immunology submission guidelines, Nature Portfolio.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Choose the practical next step for your research.
Start with the question in front of you, or use the guided learning path when you want a clearer view of the full publishing process.
Where to go next
Start here
Same journal, next question
- Nature Immunology Submission Guide
- How to Avoid Desk Rejection at Nature Immunology
- Is Nature Immunology a Good Journal? Fit Verdict
- Is Your Paper Ready for Nature Immunology? The Fundamental Discovery Test
- Nature Immunology 'Under Review': What Each Status Means
- Nature Immunology Acceptance Rate: What Authors Can Use